Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangioma × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Endometrial Neoplasms 13 Colorectal Neoplasms 12 Stomach Neoplasms 11 Lung Neoplasms 11 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Sarcoma 5 Neoplasm Metastasis 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Propranolol 9 Timolol 5 Prednisolone 4 Prednisone 3 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Methylprednisolone 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351245 2015-01-30

Clinical Characteristics of Lip Hemangiomas

Zhujiang Hospital

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡